The partnership falls under the UK’s Newton Fund, which has set aside
£75m a year for five years for partnerships that promote the economic welfare
of developing countries. The fund works with 15 countries, including SA’s Brics
partners Brazil, India and China. It will support collaborative projects
between scientists in the UK and SA in health, the environment and food
security.
Funds will be directed towards research that aims to improve SA’s
science and technology capacity, grow the economy, and create jobs, in line
with the National Development Plan’s aims, said UK Minister of State for Africa
James Duddridge. "SA leads Africa in science and innovation (and is) a
perfect fit with our ambitions for the Newton Fund to have a regional
footprint."
Both countries are expected to work closely with African countries and
to bring in private sector collaborators, such as UK drug maker
GlaxoSmithKline, which has signed up to a project with the UK Medical Research
Council and its South African counterpart.
The UK was a significant contributor to global science, and the
partnership offered "an enormous number of opportunities to work with the
best in the world", Mr Duddridge said. International scientific
collaboration was vital for tackling global challenges such as climate change,
he said.
Ms Pandor said the partnership would prioritise human capital
development. "Without the training of the next generation of scientists
and engineers, neither country will achieve its objectives for increasing
knowledge-based scientific activities," she said, before signing a
memorandum of understanding with the UK.
"The focus on big data is particularly pleasing, as the UK and SA
already co-operate within the SKA (Square Kilometre Array) project," she
said.
GlaxoSmithKline and the medical research councils have formed a
three-year partnership to collaborate in research on tuberculosis and
non-communicable diseases. "We will be studying the gaps in our knowledge
about the diversity of non-communicable diseases in Africa," said South
African Medical Research Council president Glenda Gray.
The council had committed R30m to the project on noncommunicable
diseases, while GlaxoSmithKline had agreed to put in £1m. There will also be
joint research programmes on weather and climate science, and social science
for development. Other activities include £1m in seed funding to support ties
between institutions, which will be overseen by the UK’s Medical Research
Council and the Technology Innovation Agency.
The UK council will work with the Academy of Science of SA to support
skills development, while the Royal Academies will work with the National
Research Foundation to fund 90 fellowship and 150 mobility grants.
No comments:
Post a Comment